Eli Lilly Raises Insulin Prices While Supporting People With Diabetes
Although I was often called Goldilocks as a child, I never took a liking to the story. The little girl and I both had curly blond hair, but thats where the similarity ended. AboutLittle Red Riding Hood, however, I felt differently. As a child who happily made her way to grandmas all the time, Little Red Riding Hood and I shared a bond. Sure, she had to trek through a forest and all I had to do was cross over a little bayou bridge, but our destination was the same.
I attribute much of my lost childhood innocence to Little Red Riding Hood. Thanks to her story, I learned not only to worry about being gobbled alive or hacked up by a woodcutter, but to fear being tricked. Little Red alerted me to the possibility that in the bed where my loving, somewhat overbearing, tiny, white-haired, toothless grandmother slept, I could also encounter a hairy beast in a bonnet who wanted to eat me rather than feed me. And yesterday when I read that Eli Lilly, pharmaceutical giant, raised the price of their big selling insulins, Humalog and Humilin, by 7.8% just on the heels of a meeting with diabetes advocates to discuss the problem of the high cost of insulin, I couldnt help but think of Little Red Riding Hood and the deceiving wolf.
Exactly no one should be astonished that Lilly has, yet again, hiked the price of insulin. Its just another example of greedy pharma being greedy pharma. The escalation perfectly fits the pattern of insulin drugmakers regular price increases. (Its this pattern that led Senator Bernie Sanders toaskthe Department of Justice and the Federal Trade Commission to i Continue reading